MIRA Pharmaceuticals Inc. (MIRA)
NASDAQ: MIRA
· Real-Time Price · USD
1.35
0.01 (0.75%)
At close: May 30, 2025, 3:59 PM
1.29
-4.44%
After-hours: May 30, 2025, 05:56 PM EDT
0.75% (1D)
| Bid | 1.28 |
| Market Cap | 22.84M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.92M |
| EPS (ttm) | -0.47 |
| PE Ratio (ttm) | -2.87 |
| Forward PE | -3.41 |
| Analyst | Buy |
| Ask | 1.4 |
| Volume | 104,400 |
| Avg. Volume (20D) | 1,309,980 |
| Open | 1.32 |
| Previous Close | 1.34 |
| Day's Range | 1.29 - 1.37 |
| 52-Week Range | 0.51 - 5.01 |
| Beta | 1.95 |
About MIRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MIRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MIRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+19.26%
MIRA Pharmaceuticals shares are trading higher aft...
Unlock content with
Pro Subscription
7 months ago
+21.71%
MIRA Pharmaceutical shares are trading higher after the company's new preclinical data showed that Ketamir-2 achieved 60% greater efficacy than the FDA-approved gabapentin in reducing chemotherapy-induced pain.
